China announced that GV-971 or “Oligomannate”, a new drug, meant to potentially treat Alzheimer’s disease, will be available to Chinese patients by the end of this year.
About:
GV-971 or “Oligomannate” is a seaweed-based drug, administered orally.
Chinese researchers have claimed it is capable of treating mild to moderate Alzheimer's and may improve cognition.
It has been jointly developed by the Shanghai Institute of Materia Medica and the Ocean University of China and Green Valley Pharmaceutical Company Ltd.
Dear Student,
You have still not entered your mailing address. Please enter the address where all the study materials will be sent to you. (If applicable).
